Evidence map›Paper›PMID 33447846›Full record

ArticleRheumatology (Oxford, England)2021

Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis.

Rabia Agca, Annelies B Blanken, Alper M van Sijl, Yvo M Smulders, Alexandre E Voskuyl, Conny van der Laken, Ronald Boellaard, Michael T Nurmohamed

Open access · hybridAbstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Rabia AgcaAmsterdam Rheumatology and Immunology Center, Department of Rheumatology, Reade.ORCID 0000-0002-5904-0264
Annelies B BlankenAmsterdam Rheumatology and Immunology Center, Department of Rheumatology, Reade.
Alper M van SijlAmsterdam Rheumatology and Immunology Center, Department of Rheumatology, Reade.
Yvo M SmuldersDepartment of Internal Medicine.
Alexandre E VoskuylAmsterdam Rheumatology and Immunology Center, Department of Rheumatology, VU University Medical Center.
Conny van der LakenAmsterdam Rheumatology and Immunology Center, Department of Rheumatology, VU University Medical Center.
Ronald BoellaardDepartment of Nuclear Medicine, Amsterdam University Medical Centers, VU University Medical Center, Amsterdam, The Netherlands.
Michael T NurmohamedAmsterdam Rheumatology and Immunology Center, Department of Rheumatology, Reade.
University Medical Center · USAmsterdam University Medical Centers · NLReade · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRA is associated with higher risk of cardiovascular (CV) disease. Ongoing systemic inflammation is presumed to accelerate atherosclerosis by increasing inflammation in the arterial wall. However, evidence supporting this hypothesis is limited. We aimed to investigate arterial wall inflammation in RA vs OA, and its association with markers of inflammation and CV risk factors.

methods18-fluorodeoxyglucose PET combined with CT (18F-FDG-PET/CT) was performed in RA (n = 61) and OA (n = 28) to investigate inflammatory activity in the wall of large arteries. Secondary analyses were performed in patients with early untreated RA (n = 30), and established RA, active under DMARD treatment (n = 31) vs OA.

resultsPatients with RA had significantly higher 18F-FDG uptake in the wall of the carotid arteries (beta 0.27, 95%CI 0.11-0.44, P <0.01) and the aorta (beta 0.47, 95%CI 0.17-0.76, P <0.01) when compared with OA, which persisted after adjustment for traditional CV risk factors. Patients with early RA had the highest 18F-FDG uptake, followed by patients with established RA and OA respectively. Higher ESR and DAS of 28 joints values were associated with higher 18F-FDG uptake in all arterial segments.

conclusionPatients with RA have increased 18F-FDG uptake in the arterial wall compared with patients with OA, as a possible marker of early atherosclerosis. Furthermore, a higher level of clinical disease activity and circulating inflammatory markers was associated with higher arterial 18F-FDG uptake, which may support a role of arterial wall inflammation in the pathogenesis of vascular complications in patients with RA.

Indexed as

AgedAntirheumatic AgentsAortaArteriesArthritis, RheumatoidAtherosclerosisCarotid ArteriesCase-Control StudiesFemaleFemoral ArteryHumansIliac ArteryInflammationMaleMiddle AgedOsteoarthritisAntirheumatic AgentsatherosclerosisFDG PET/CTinflammationRA

Identifiers

PMID33447846
PMCPMC8516502
OpenAlexW3122908487

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.